Epredia is a privately held anatomical and digital pathology equipment company headquartered in Portsmouth, New Hampshire, and Kalamazoo, Michigan, delivering workflow solutions and diagnostic instruments.
Subscribe to see Epredia’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Epredia is a medical devices company headquartered in United States. Xcout tracks 10 named people at Epredia, including Steven Lynum (President & CEO). Xcout recorded 2 job postings from Epredia in the last 90 days.
4 more named people on record for Epredia, with roles, board committees and tenure — see the full roster →
Xcout recorded 2 job postings from Epredia in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Epredia's hiring signals →
A few of Epredia's closest competitors — see the full list of competitors and alternatives →
Clarapath, Inc. is a U.S. medical-technology company developing robotic automation systems for anatomical pathology and histology workflows, including tissue processing and slide preparation. Its products are intended for hospital, clinical, and pathology laboratories to improve the efficiency and consistency of diagnostic specimen preparation.
Laborie Medical Technologies Corp. is a medical technology company headquartered in Portsmouth, New Hampshire. The company specializes in medical devices and diagnostics for specialties such as urology and gastroenterology.
Instapath Inc. is a biotechnology research company specializing in transforming tissue, headquartered in Houston, Texas.
CellaVision provides digital hematology microscopy solutions, including hardware analyzers, instruments, reagents, and specialized software applications. The company automates and streamlines workflows for human and veterinary laboratories of all sizes to analyze blood and body fluid samples.
Siemens Healthineers AG, operating through its various subsidiaries, is dedicated to the development, production, and worldwide distribution of a comprehensive portfolio of diagnostic and therapeutic solutions for healthcare professionals. The company's operations are structured across four primary segments: Imaging, Diagnostics, Varian, and Advanced Therapies. Within the Imaging segment, customers access advanced technologies such as magnetic resonance imaging (MRI), computed tomography (CT), X-ray systems, molecular imaging, and ultrasound equipment. The Diagnostics segment delivers a range of in-vitro diagnostic products and services, catering to laboratory, molecular, and point-of-care diagnostic needs, alongside specialized workflow solutions for laboratories and informatics tools. The Varian segment specializes in advanced cancer care technologies, providing a suite of solutions and services to oncology departments within hospitals and clinics. This includes optimized, technology-enabled workflows, comprehensive clinical and consulting services, and innovative digital applications designed for managing patient treatment and therapy pathways. For image-guided minimally invasive procedures in fields like cardiology, interventional radiology, and surgery, the Advanced Therapies segment offers specialized products. Its portfolio encompasses angiography systems, mobile C-arms, and an advanced robotic-assisted platform specifically engineered for endovascular coronary and peripheral vascular interventions. Beyond these core offerings, Siemens Healthineers also provides essential support services. These include equipment performance management, clinical education and e-learning programs, asset management, and outsourced departmental services for both laboratories and wider healthcare facilities, complemented by consulting and digital health services. The company's corporate headquarters are situated in Erlangen, Germany, and it operates as a subsidiary of Siemens Aktiengesellschaft.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.